Navigation Links
Paragon Bioservices to Partner and Exhibit at the 2011 BIO International Convention
Date:6/9/2011

BALTIMORE, June 9, 2011 /PRNewswire/ -- Paragon Bioservices, Inc., a Baltimore-based contract research and GMP manufacturing organization, announced today that representatives from the company will be participating in the 2011 BIO International Convention's One-on-One Partnering Meetings being held on June 27-30 in Washington, D.C. at the Walter E. Washington Convention Center.

Founded in 1990, Paragon Bioservices is a CMC Center of Excellence delivering research, development and cGMP manufacturing services to pharmaceutical companies, biotechnology companies and federal agencies. With a focus on vaccines (VLPs), monoclonal antibodies, therapeutic proteins and stem cells, Paragon's role is to bridge the translational divide and to enable vaccines—as well as proteins and cell-based therapeutics—to move from the research bench into Phase I/II clinical trials.

Representatives available to discuss Paragon's capabilities include: Dr. Marco Chacon, President & CEO; Jessica Boehmer, Director of Sales & Business Development; Dr. Philip Wills, Corporate Scientific Liaison; and Dr. Aaron Heifetz, Stem Cell & Regenerative Medicine.  Companies or individuals attending BIO 2011 can schedule meetings with Paragon by visiting: http://oneononepartnering.bio.org/BusinessForum2011/Login.aspx. Partnering Schedule:Monday, June 27Business Forum  -  12:00 p.m. – 5:00 p.m.Tuesday, June 28Business Forum  -  8:00 p.m. – 5:00 p.m.Wednesday, June 29Business Forum  -  8:00 a.m. – 5:00 p.m.Thursday, June 30Business Forum  -  8:00 a.m. – 5:00 p.m.For companies or individuals not participating in partnering meetings, Paragon will be exhibiting in booth number 1657 located in Hall A – BIO Process Zone.

About Paragon Bioservices, Inc.Located in Baltimore, Maryland, Paragon Bioservices is a privately held contract research and manufacturing organization (CMO) with a focus on the development and manufacturing of biopharmaceuticals—either for research purposes or clinical trials. Working as an outsourcing partner and with a long standing tradition of quality and service, Paragon expands the capabilities of pharmaceutical companies, biotechnology companies and government agencies involved in the development of monoclonal antibodies, therapeutic proteins, vaccines/VLPs and stem cells.

For more information visit: www.paragonbioservices.com.

Media Contacts:Tiberend Strategic Advisors, Inc.  (212) 827-0020
Tamara Bright tbright@tiberend.com or Claire Sojda csojda@tiberend.com


'/>"/>

SOURCE Paragon Bioservices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
2. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
3. Surgical Information Systems Partners with Siemens to Deliver Advanced Perioperative Solutions to Enterprise Health Information System Customers
4. COPAN Announces Strategic Global Distribution Partnership with Siemens
5. AmeriCares Honors AstraZeneca with Power of Partnership Award
6. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
7. University of Pennsylvania Announces Partnership with Chinese Academy of Sciences for Center of Excellence in Brain Mapping
8. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
9. Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
10. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
11. Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):